← FDA Warning Letters
ImprimisRx NJ
FDA Warning Letter · 2023-06-06 · Division of Pharmaceutical Quality Operations I
Letter
- Company
- ImprimisRx NJ
- Posted Date
- 2023-06-06
- Letter Issue Date
- 2023-05-26
- Issuing Office
- Division of Pharmaceutical Quality Operations I
Subject
Compounding Pharmacy/Adulterated Drug Products
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown